|
Ranbaxy Laboratories Ltd
Executive Summary
Ranbaxy, India’s #1 pharmaceutical company has major strengths in therapeutic areas of Anti-Infective, Dermatology, GI Tract, NSAIDs, CNS, Orthopedics and Cardiovascular. ...
Ranbaxy aims to become global player achieving sales of $1bn by 2004. ... On domestic front, Ranbaxy has consolidated its position and enhanced therapeutic span, through brand acquisitions/ company takeovers. Its deal with Bayer AG, Germany to develop once a day Ciprofloxacin has made Ranbaxy a truly transnational research driven pharmaceutical company. Ranbaxy is ranked as the 11th largest Public Generics Company in the world, by a US publication.
Approximate Word count = 395
Approximate Pages = 1.6
(250 words per page double spaced)
|
|
